Figure 1.
hMSCs retain their phenotype in the presence of IL-1β. (A) Quantification of the concentration of IL-1β in the cell medium upon initial addition of either control or IL-1β medium to cells and after 1 and 7 days in culture as measured by ELISA. N = 10 replicates for each condition. Parametric one-way ANOVA, Tukey multiple comparison test. (B) Quantification of DNA concentration of hMSCs after 1 and 7 days in culture. N = 27 replicates for each condition. Non-parametric Kruskal–Wallis test with Dunn’s multiple comparison test. ***p < 0.001. Box and whisker plots represent minimum to maximum. (C,D) Representative flow cytometry dot plots of forward scatter (FSC-H) versus APC fluorescence intensity for the cell surface markers CD44, CD73, CD90 and CD105 for control and IL-1β treated (10 ng/mL) hMSCs following (C) 1 day or (D) 7 days in culture. Gating strategy and analysis are in Supplementary Figure S1.
